Company intelligence
OZ Biosciences
OZ Biosciences creates, develops and commercializes life sciences reagents specialized in transfection and transduction
About OZ Biosciences
OZ Biosciences is a product development company that creates, develops and commercializes delivery systems of bioactive materials (DNA, siRNA, proteins, antibodies...), intended for the worldwide scientific community and pharmaceutical industries. Our mission is to assist scientists to accelerate the rhythm of discoveries by offering them technologically advanced tools such as transfection reagents and other life science research products. Principal innovations are based on proprietary technologies such as Magnetofection (magnetic-assisted transfection or infection), Magneto-Biolistic, transfection reagents, transduction tools, mRNA and lipids-based delivery systems (LNP). Specialized and expert in drug delivery systems, we also provide custom transfection, mRNA and LNP services and are involved in many international research projects. For more info, please contact: contact@ozbiosciences.com or contactusa@ozbiosciences.com (North America).
Verified activity
Signals from OZ Biosciences
3 published signals
Legal & Regulatory
OZ Biosciences received a patent on modified poloxamers in Australia covering the method for synthetically modifying poloxamers to confer additional biological properties, including their association with viral vectors such as lentivirus, AAV, and adenovirus, as well as magnetic nanoparticles.
Reported by OZ Biosciences
Research & Knowledge
OZ Biosciences published a study in Science Advances by Hiroshi Kobayashi et al identifying Pbx1 as a key driver of hematopoietic stem cell aging.
Reported by OZ Biosciences
Presence & Recognition
OZ Biosciences participated in the 6th edition of Innovative Therapies Days in Besançon, France on October 8–9.
Reported by OZ Biosciences